Abstracts

Search by keyword or author name.

Showing 851 abstracts.

Diane W. Wara, M.D. Safety of Recombinant HIV-1 Envelope Vaccines in Newborns of Infected Mothers - a Phase I Study.
Lynne M. Mofenson, M.D., F.A.A.P. Pharmacokinetics of P24 Antibody (Ab) in HIV+ Pregnant Women & Newborns Receiving Hyperimmune HIV Immunoglobulin (HIVIG) in ACTG Protocol 185.
John S. Lambert, M.D. Safety and Pharmacokinetics of Hyperimmune HIV Immunoglobulin (HIVIG) in HIV+ Pregnant Women and Newborns.
James M. Oleske, M.D., Mary Glenn Fowler, M.D., M.P.H., Michael T. Brady, M.D. AIDS Clinical Trials Group (ACTG) Protocol 219: A PediatricHIV Late Outcomes Protocol.
Vincent J. Carey, Ph.D. Enhancing the Prognostic Value of Bodily Growth Histories in HIV-Positive Pediatric Cohorts.
Faith Doyle, R.N.,B.S.N. Perinatal AIDS Clinical trials - Integrating Research Into Primary Care "The Miami Experience".
Lawrence D'Angelo, M.D., M.P.H. The Enrollment of HIV Infected Adolescents in Clinical Trials: The Experience of ACTG Protocol 220.
Colleen Clark, M.Ph. Quality of Life Outcomes in Children 6 Months to 4 Years of Age Born of Women Enrolled in a Perinatal HIV Transmission Clinical Trial.
Donald J. Brambilla, Ph.D. Interkit Differences in Plasma HIV-1 RNA Levels in Mothers Enrolled in WITS/ACTG 076.
Elizabeth Livingston, M.D., Sheran Patel, D.O., Jashvant D. Unadkat, Ph.D., Ross E. McKinney, Jr., M.D., Arlene D. Bardeguez, M.D., M.P.H., F.A.C.O.G., Mary Jo O'Sullivan, M.D. Placental Transfer of Didanosine (ddI) and Initial Evaluation of Didanosine Toxicity in HIV-1 Infected Pregnant Women and their Offspring.